Therapeutic Uses
Antiretroviral / Anti-HIV
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
1-(2-(methyl-d3)propyl-2,3,3,3-d4)-1H-imidazo[4,5-c]quinolin-4-amine
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
Imiquimod-d7 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Imiquimod-d7 usage and description
Imiquimod D7 is a synthetic and deuterated analogue of the immune response modifier Imiquimod. It is commonly used to treat external genital and perianal warts caused by human papillomavirus (HPV), as well as actinic keratosis, superficial basal cell carcinoma, and other skin conditions.
The mechanism of action of Imiquimod D7 involves activation of the immune system, particularly the innate immune system, to produce cytokines and chemokines that stimulate the immune response against viral and cancerous cells. This immune response results in the destruction of the infected or abnormal cells.
Imiquimod D7 is applied topically to the affected area and is typically used for several weeks until the condition resolves. It is available as a 5% cream or a 3.75% pump. It should not be used on open wounds or mucous membranes, and caution should be used when applying it near the eyes.
Imiquimod D7 is metabolized in the liver and excreted primarily in the urine. It has a half-life of approximately 10 hours and is eliminated from the body within 24 hours of application. It has no significant drug interactions, and there is no evidence of systemic toxicity with normal use.
In conclusion, Imiquimod D7 is a safe and effective treatment option for various skin conditions, particularly those caused by HPV. Its unique mechanism of action and minimal side effects make it a popular choice for dermatologists and patients alike.
